FDA Clearance Tracker · K182012
ADVIA Centaur Calcitonin (CALCT) assay
Last checked: Nov 19, 2026Latest source record: Dec 21, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Dec 21, 2018
Substantially Equivalent
Time to decision
147 days
Received Jul 27, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K182012
- Device name
- ADVIA Centaur Calcitonin (CALCT) assay
- Applicant
- Axis-Shield Diagnostics Limited
- Applicant location
- Dundee, GB
- Received
- Jul 27, 2018
- Decided
- Dec 21, 2018
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Radioimmunoassay, Calcitonin (JKR)
- Device class
- Class II
- Regulation
- 21 CFR 862.1140
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code JKR. The earliest in FDA's data is K781909, decided Jan 10, 1979.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K182012
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Axis-Shield Diagnostics Limited
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K183088 · Decided Aug 2, 2019 · 269 days after receipt
Device type: Assay, Erythropoietin (GGT) · Laboratory Medicine & Pathology
K153551 · Decided Aug 4, 2016 · 237 days after receipt
Device type: Antibodies, Anti-Cyclic Citrullinated Peptide (Ccp) (NHX) · Laboratory Medicine & Pathology
K160757 · Decided Jul 26, 2016 · 130 days after receipt
Device type: Radioassay, Vitamin B12 (CDD) · Laboratory Medicine & Pathology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.